Inhaled / Nasal Applications

Novel dry powder formulations for inhaled or nasal delivery have been produced. They have exhibited improved therapeutic endpoints compared to conventional dry or liquid formulations for low molecular-weight compounds for local or systemic delivery; biologically active peptides; and vaccines against infectious pathogens. Formulation and delivery of novel nanoparticles offers advantages, including:

• higher shelf-life stability
  

• better control of particle size and deposition efficiency
  

• control of cell uptake and targeting
  

• controlled release-rates
  

• increased systemic bioavailability